Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
69
JAZZ Quote, Financials, Valuation and Earnings
Last price:
$170.79
Seasonality move
:
4.89%
Day range:
$169.50 - $172.69
52-week range:
$95.49 - $182.99
Dividend yield:
0%
P/E ratio:
15.09x
P/S ratio:
2.51x
P/B ratio:
2.62x
Volume:
313.4K
Avg. volume:
1.4M
1-year change:
38.04%
Market cap:
$10.4B
Revenue:
$4.1B
EPS (TTM):
-$6.07
Earnings Data
Next earnings date for JAZZ
Feb 24
2026
Most recent earnings per share
$4.08
Missed by $1.77
(Nov 5/2025)
Consensus Estimate
$5.85
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JAZZ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $1.2B | -- | -- | $6.41 | -- |
| 11/05/2025 | Q3 | $1.1B | $1.1B | $4.08 | $5.85 | -$1.77 |
| 08/05/2025 | Q2 | $1B | $1B | -$11.74 | -$6.25 | -$5.49 |
| 05/06/2025 | Q1 | $983.8M | $897.8M | -$1.52 | $4.66 | -$6.17 |
| 02/25/2025 | Q4 | $1.1B | $1.1B | $3.11 | $5.81 | -$2.70 |
| 11/06/2024 | Q3 | $1B | $1.1B | $3.40 | $5.50 | -$2.10 |
| 07/31/2024 | Q2 | $1B | $1B | $2.42 | $4.78 | -$2.36 |
| 05/01/2024 | Q1 | $954.3M | $902M | -$0.23 | $4.18 | -$4.41 |
| 02/28/2024 | Q4 | $1B | $1B | $1.35 | $5.18 | -$3.83 |
| 11/08/2023 | Q3 | -- | $972.1M | $2.06 | -- | -- |
| 08/09/2023 | Q2 | -- | $957.3M | $1.42 | -- | -- |
| 05/10/2023 | Q1 | -- | $892.8M | $0.94 | -- | -- |
| 03/01/2023 | Q4 | -- | $972.1M | -$3.82 | -- | -- |
| 11/09/2022 | Q3 | -- | $940.7M | -$0.31 | -- | -- |
| 08/03/2022 | Q2 | -- | $932.9M | $0.55 | -- | -- |
| 05/04/2022 | Q1 | -- | $813.7M | $0.03 | -- | -- |
| 03/01/2022 | Q4 | -- | $896.7M | -$0.57 | -- | -- |
| 11/09/2021 | Q3 | -- | $838.1M | -$0.86 | -- | -- |
| 08/03/2021 | Q2 | -- | $751.8M | -$6.11 | -- | -- |
| 05/04/2021 | Q1 | -- | $607.6M | $2.09 | -- | -- |
| 02/23/2021 | Q4 | -- | $665.5M | $2.33 | -- | -- |
| 11/02/2020 | Q3 | -- | $600.9M | $2.64 | -- | -- |
| 08/04/2020 | Q2 | -- | $562.4M | $2.06 | -- | -- |
| 05/05/2020 | Q1 | -- | $534.7M | -$2.82 | -- | -- |
| 02/25/2020 | Q4 | -- | $581.7M | $1.29 | -- | -- |
| 11/05/2019 | Q3 | -- | $537.7M | $1.78 | -- | -- |
| 08/06/2019 | Q2 | -- | $534.1M | $4.56 | -- | -- |
| 05/07/2019 | Q1 | -- | $508.2M | $1.47 | -- | -- |
| 02/26/2019 | Q4 | -- | $476.5M | $2.64 | -- | -- |
| 11/06/2018 | Q3 | -- | $469.4M | $2.41 | -- | -- |
| 08/07/2018 | Q2 | -- | $500.5M | $1.50 | -- | -- |
| 05/08/2018 | Q1 | -- | $444.6M | $0.75 | -- | -- |
| 02/27/2018 | Q4 | -- | $436.4M | $3.79 | -- | -- |
| 11/07/2017 | Q3 | -- | $411.9M | $1.03 | -- | -- |
| 08/08/2017 | Q2 | -- | $394.4M | $1.72 | -- | -- |
| 05/09/2017 | Q1 | -- | $376.1M | $1.41 | -- | -- |
| 02/28/2017 | Q4 | -- | $396.6M | $1.91 | -- | -- |
| 11/08/2016 | Q3 | -- | $374.2M | $1.45 | -- | -- |
| 08/09/2016 | Q2 | -- | $381.2M | $1.85 | -- | -- |
| 05/10/2016 | Q1 | -- | $336M | $1.21 | -- | -- |
| 02/23/2016 | Q4 | -- | $340.9M | $1.32 | -- | -- |
Jazz Pharmaceuticals Plc Earnings Questions
-
How Much did Jazz Pharmaceuticals Plc Generate in Revenue Last Quarter?
Jazz Pharmaceuticals Plc reported $1.1B worth of top line sales in its most recent quarter.
-
Did Jazz Pharmaceuticals Plc Beat Earnings Last Quarter?
Jazz Pharmaceuticals Plc announced earnings per share of $4.08 which represents a miss of analyst forecast a $5.85 per share.
-
Is Jazz Pharmaceuticals Plc Profitable?
Jazz Pharmaceuticals Plc reported $828.9M that represents $13.45 per share over the last quarter.
-
What is the Analyst Consensus for Jazz Pharmaceuticals Plc EPS Next Year?
Jazz Pharmaceuticals Plc's earnings are forecast to decrease from $8.65 per share to $20.21 per share next year representing a decrease of -6.31%.
-
When is Jazz Pharmaceuticals Plc's Earnings Date?
Jazz Pharmaceuticals Plc's next earnings date is February 24, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
